On March 25, 2025, the Milwaukee Bucks announced that their star point guard, Damian Lillard, has been diagnosed with deep vein thrombosis (DVT) in his right calf. This serious medical condition, characterised by the formation of a blood clot in a deep vein, has sidelined the nine-time All-Star indefinitely, casting uncertainty over his 2025 season, his long-term career, and the Bucks’ trajectory as a championship contender. As the NBA playoffs loom just weeks away, this development raises critical questions about Lillard’s health, his future on the court, and how the Bucks will adapt without one of their cornerstone players.
What is Deep Vein Thrombosis?
Deep vein thrombosis occurs when a blood clot forms in a deep vein, most commonly in the legs or calves. While it can sometimes present with minimal symptoms—like soreness or swelling—it carries significant risks if untreated. If a clot dislodges, it can travel to the lungs, causing a potentially life-threatening pulmonary embolism. In Lillard’s case, the Bucks acted swiftly, identifying the condition and placing him on blood-thinning medication to stabilize the clot. Regular testing will monitor his progress, but no definitive timeline for his return has been provided, leaving his season in jeopardy.
For an elite athlete like Lillard, who relies on explosive movement, agility, and endurance, DVT introduces both immediate and long-term challenges. The Bucks have emphasized that his health is the top priority, a sentiment Lillard echoed in a statement: “As much as I love basketball, I need to be there for my kids and my family.” While there’s optimism about his recovery, the road ahead is uncertain.
Impact on the 2025 Season
Lillard’s diagnosis comes at a pivotal moment. With only 11 games left in the regular season as of March 26, 2025, the Bucks sit at 40-31, holding the fifth seed in the Eastern Conference. Lillard has been a driving force this year, averaging 24.9 points, 7.1 assists, and 4.7 rebounds per game while earning his ninth All-Star nod. His partnership with Giannis Antetokounmpo has produced the NBA’s highest-scoring duo, averaging 55.1 points combined. Without him, the Bucks’ offense takes a significant hit—scoring drops from 115.7 points per game with Lillard to 108.5 without him, per team stats.
The playoffs begin on April 19, less than a month away. For Lillard to return by then, his recovery would need to be remarkably swift and complication-free, a tall order given the nature of DVT. Treatment typically involves blood thinners for weeks or months, and medical clearance for high-intensity activity requires strict criteria to ensure the clot has dissolved and the risk of recurrence is minimal. Even if he beats the odds and returns for the postseason, he may not be at full strength, potentially limiting his minutes or effectiveness.
In his absence, the Bucks will lean on younger guards like Ryan Rollins and Kevin Porter Jr., who bring defensive tenacity but lack Lillard’s offensive creativity and clutch scoring. Giannis Antetokounmpo remains a one-man wrecking crew, but without Lillard’s playmaking, opposing defenses can focus on clogging the paint, forcing Milwaukee to rely on less dynamic options. The team’s 8-5 record in the 13 games Lillard has missed this season offers some hope, but the postseason is a different beast. Last year’s first-round exit—when Antetokounmpo missed the entire series with a calf injury—underscores how vulnerable the Bucks are without one of their superstars.
Long-Term Career Implications
At 34 years old and in his 13th NBA season, Lillard is at a career crossroads. He’s no longer the perennial All-NBA talent he was during his Portland Trail Blazers prime, but he remains a top-tier guard capable of leading a contender. However, DVT introduces new variables. While the Bucks and medical experts are optimistic that this is an isolated incident unlikely to recur, the condition has ended careers before—most notably Chris Bosh’s in 2016 after recurrent blood clots. Other players, like Brandon Ingram and Victor Wembanyama (who was ruled out for the season in February 2025 with DVT in his shoulder), have faced similar diagnoses with varying outcomes.
If Lillard’s treatment progresses smoothly, he could return to form by next season, leveraging advancements in medical care that have improved recovery prospects since Bosh’s era. However, any recurrence or complications—like the need for lifelong blood thinners—could force him to reconsider contact sports. Even a single prolonged absence might accelerate the natural decline that comes with age, especially for a player whose game relies on quickness and precision.
Lillard’s resilience and work ethic suggest he’ll fight to reclaim his elite status, but the physical toll of DVT, combined with the mental weight of a serious health scare, could subtly alter his trajectory. His statement about prioritizing family hints at a broader perspective that might influence future decisions about his career’s length and intensity.
The Bucks’ Future in Flux
The Bucks’ acquisition of Lillard in 2023 was a bold gamble to maximize Giannis Antetokounmpo’s championship window, trading away Jrue Holiday and betting on Lillard’s offensive firepower. Two seasons in, the results have been mixed—an In-Season Tournament title but no deep playoff run. Now, with Lillard sidelined and Antetokounmpo carrying the load, the team faces a precarious future.
If Lillard misses the playoffs or returns diminished, the Bucks’ title hopes for 2025 could evaporate, especially in a loaded Eastern Conference led by the Boston Celtics and Cleveland Cavaliers. A second straight early exit might prompt soul-searching in Milwaukee. Antetokounmpo, still in his prime at 30, remains the franchise’s bedrock, but the supporting cast—minus Khris Middleton, traded at the deadline—lacks the star power to compensate for Lillard’s absence long-term.
The front office, led by GM Jon Horst, will need to weigh whether this iteration of the roster can still contend or if a retooling is necessary. Lillard’s contract runs through 2026-27 (with a player option), tying up significant cap space. If his health remains a question mark, the Bucks could face a difficult choice: double down on the current core or pivot to a younger, healthier supporting cast around Giannis.
A Path Forward
For now, the focus is on Lillard’s recovery. The Bucks’ proactive approach—consulting top hematologists and starting treatment quickly—bodes well for his prognosis. Fans and analysts alike are hopeful he can defy the odds and return this season, even if only for a limited playoff role. His legacy as one of the game’s greats is secure, but the chance to add a championship with Milwaukee hangs in the balance.
As for the Bucks, adaptability will be key. Coach Doc Rivers must reimagine the offense, leaning into Antetokounmpo’s dominance and the defensive identity that players like Rollins and Porter can reinforce. The team’s depth will be tested, but their championship pedigree offers a glimmer of resilience.
Damian Lillard’s DVT diagnosis is a stark reminder of the fragility of even the most elite athletes. His season may be in jeopardy, his career at a turning point, and the Bucks’ future uncertain—but if anyone can navigate this challenge, it’s Dame Time. The basketball world waits, hoping for a comeback worthy of his storied career.
Lillard’s absence places an even greater burden on Giannis as the Bucks’ primary superstar. The team has built its championship aspirations around the Lillard-Antetokounmpo duo since acquiring Lillard in a blockbuster trade in 2023. With Lillard out, Giannis will need to shoulder more of the offensive and leadership load, especially as the playoffs approach. If the Bucks struggle without Lillard—particularly if they falter in the postseason again, as they did last year when Giannis was injured—this could amplify existing narratives about Milwaukee’s inability to maximize Giannis’s prime. Teams eyeing Giannis might see this as an opportunity to speculate on his frustration, given his past comments about needing a championship-contending environment to stay long-term.
However, Giannis’s trade market isn’t likely to shift dramatically in the short term. His contract runs through the 2024-25 season, with a player option for 2025-26, giving Milwaukee some runway before he could hit free agency. The Bucks’ acquisition of Lillard was a clear signal of their commitment to Giannis, and despite this setback, they’re not in a position to dismantle that plan yet. Lillard’s prognosis offers cautious optimism—he’s on blood thinners, and there’s hope he could return this season, though no firm timeline exists. If he does return for the playoffs, it could stabilise the Bucks’ outlook and quiet any trade chatter around Giannis.
That said, Lillard’s injury could indirectly lower Giannis’s trade value by highlighting Milwaukee’s vulnerabilities. Rival teams might perceive the Bucks as a less stable destination, especially after two straight first-round playoff exits (one due to Giannis’s injury last year). If Lillard’s recovery stretches into next season or beyond—medical experts have suggested a potential three-month timeline, which could rule him out for the postseason—opposing GMs might question whether Giannis can carry a depleted roster deep into the playoffs alone.
What I think will happen: nothing changes. Bucks have no chance in the playoffs with or without Dame. Now they have a convenient excuse. Giannis plays hero ball, statpads like crazy, nobody blames him for early exit. Dame’s injury gives him a great excuse to stay in Milwaukee citing team loyalty in this tough time for them. He was never leaving anyway.
